Actively Recruiting
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Led by Hacettepe University · Updated on 2025-08-24
200
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
CONDITIONS
Official Title
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Had a CT scan at the L3 level before treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
You will not qualify if you...
- Did not provide written informed consent
- Patients deemed unsuitable by the physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy
Ankara, Altındağ, Turkey (Türkiye), 06100
Actively Recruiting
Research Team
İ
İzgi BAYRAKTAR, PhD (c)- Lecturer
CONTACT
A
Aygin Ekincioglu, Prof.Dr. -Head of department
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here